Noa approaches direct investing by targeting companies where through our ecosystem we can deliver a real market advantage by a hands-on value-add approach.
Noa is an early investor in Clinova, a leading consumer healthcare Company. A healthcare business built to understand customer needs, with effective physical products and technology.
Noa has supported Clinova growth aspirations in the Middle-East by opening new markets across the Gulf through Joint Venture Partners, securing strategic investors, record breaking contracts, Talent and Board Members.